Open Orphan - Confirmation of Hvivo acquisition
ORPH Fri, 10 Jan 2020, 02:30pm GMT
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland
Cathal Friel, Chief Executive of Open Orphan, discusses the Hvivo acquisition and the management team of the group going into 2020.